Type:Notice
Citation:90 FR 5900
Reading Time:about a minute or two
The Food and Drug Administration (FDA) issued a notice about withdrawing a previous announcement made on October 18, 2023, concerning a proposed study aimed at improving the quality of data for treatment centers. This decision was made because of issues related to the circumstances and timing of the study's execution. As a result, the FDA has canceled their plan to move forward with the study and withdrawn the previous notice. The withdrawal became effective on January 17, 2025.
Simple Explanation
The FDA decided to stop a plan they had announced earlier about improving data for treatment centers because it wasn't the right time to continue. Now they have officially canceled that plan.